Fenofibric acid clinical trials
Also written FIBRICOR.
Includes 19 studies of Choline fenofibrate.
How each study uses fenofibric acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the fenofibric acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 15 Dec 2008 · TRILIPIX · NDA 022224 (FDA, Drugs@FDA; as choline fenofibrate)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
27 studies that test it; most in 2008 (10)
| Year | Studies |
|---|---|
| 2006 | 4 |
| 2007 | 5 |
| 2008 | 10 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 22 · Other 5
Abbott (7) · Mutual Pharmaceutical Company, Inc. (6) · AstraZeneca (4) · AbbVie (prior sponsor, Abbott) (1) · Chong Kun Dang Pharmaceutical (1) · University of Pennsylvania (1) · Daewoong Pharmaceutical Co. LTD. (1) · Hanmi Pharmaceutical Company Limited (1)
Often tested with
Tested in the same studies.
Atorvastatin (2) · Fenofibrate (2) · CRESTO 20MG (1) · Ezetimibe (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypolipidemic Agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test fenofibric acid.
- Dec 2026Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaPhase 4 · Seoul National University Bundang Hospital
Studies
Open first, then newest update. How each study uses fenofibric acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 27
- Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined DyslipidemiaRecruitingPhase 4Seoul National University Bundang HospitalNCT05365425Written as Choline fenofibrateHow we know
- AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary AtherosclerosisWithdrawnPhase 3Piedmont HealthcareNCT01030328Written as TriLipixHow we know
- Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the BloodCompletedPhase 3AbbVie (prior sponsor, Abbott)NCT00616772Written as ABT-335How we know
- CKD-337(2) Drug-drug Interaction StudyCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02422030Written as Trilipix 135mgHow we know
- Study of Trilipix Effects on Lipids and ArteriesTerminatedPhase 4University of UtahNCT01025492Written as TrilipixHow we know
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility StudyCompletedPhase 2University of PennsylvaniaNCT00728910Written as ABT335How we know
- Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male VolunteersCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT01964365Written as Fenofibric acid 135mgHow we know
- Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 CapsuleCompletedPhase 1Hanmi Pharmaceutical Company LimitedNCT01555398Written as HIP0901 capsule (Fenofibric acid) Fasting conditions/ Fed conditionsHow we know
- 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney DiseaseCompletedPhase 3AstraZenecaNCT00680017Written as ABT-335 plus rosuvastatinHow we know
- A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With DyslipidemiaCompletedPhase 3AstraZenecaNCT00463606Written as ABT-335 and rosuvastatin calciumHow we know
- Interaction Between ABT-335, Rosuvastatin and WarfarinCompletedPhase 1AstraZenecaNCT00487136Written as warfarin plus ABT-335 plus rosuvastatin 5 mgHow we know
- Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered ConcomitantlyCompletedPhase 1AstraZenecaNCT00585143Written as ABT-335How we know
- Drug-Drug Interaction Study Between Fenofibric Acid and EfavirenzCompletedPhase 1Mutual Pharmaceutical Company, Inc.NCT00960570Written as Fenofibric AcidHow we know
- A Drug-Drug Interaction Study Between Fenofibric Acid and EfavirenzCompletedPhase 1Mutual Pharmaceutical Company, Inc.NCT01472380Written as fenofibric acid 105 mgHow we know
- Fasted Pharmacokinetic and Bioequivalency Study of Fenofibric AcidCompletedPhase 1Mutual Pharmaceutical Company, Inc.NCT00961259Written as Fenofibric Acid 35 mg TabletHow we know
- Effect of Choline Fenofibrate (SLV348) on Macular EdemaCompletedPhase 2Abbott ProductsNCT00683176Written as Choline FenofibrateHow we know
- Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the BloodCompletedPhase 3AbbottNCT00639158Written as ABT-335How we know
- ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) StudyCompletedPhase 1/2Radiant ResearchNCT00673881Written as choline fenofibrateHow we know
- A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and EzetimibeCompletedPhase 1AbbottNCT00681525Written as ABT-335How we know
- Comparison of Fenofibric Acid Bioavailability From ABT-335 CapsulesCompletedPhase 1AbbottNCT00839293Written as ABT-335How we know
See all 27 studies that test fenofibric acid →
Given beside what is tested · 2 — fenofibric acid is usual care or a partner of the new treatment
- Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsRecruitingPhase 2Medical University of ViennaNCT01356290Written as Fenofibric acidHow we know
- A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed DyslipidemiaCompletedPhase 3AbbottNCT00491530Written as ABT-335How we know
As the comparator · 6 — what is tested is compared with fenofibric acid
- To Compare Safety and Pharmacokinetic Properties of CJ-30039 and Lipidil SupraCompletedPhase 1HK inno.N CorporationNCT01501435Written as fenofibric acidHow we know
- Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High TriglyceridesWithdrawnPhase 3Essentialis, Inc.NCT00973271Written as 135 mg fenofibric acidHow we know
- Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form.CompletedPhase 1AstraZenecaNCT00728780Written as ABT-335 and rosuvastatinHow we know
- Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From 5/45 mg Strength of ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) 45 mg and Rosuvastatin Calcium 5 mgCompletedPhase 1AstraZenecaNCT00826358Written as ABT-335How we know
- Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin CalciumCompletedPhase 1AstraZenecaNCT00681395Written as ABT-335How we know
- Comparison of the Bioavailability of Fenofibric Acid and Rosuvastatin From ABT-143 Relative to That From the Coadministration of ABT-335 (Fenofibric Acid) and Rosuvastatin CalciumCompletedPhase 1AstraZenecaNCT00808678Written as ABT-335How we know
Codes
What other systems call fenofibric acid · ClinicalTrials.gg INT002358
- MeSH (NLM) C006012fenofibric acidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) BGF9MN2HU1FENOFIBRIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 24852Confirmed FDA, Wikidata
- Wikidata Q27077290fenofibric acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83804Fenofibric AcidOne source FDA
- DrugBank DB13873One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C006012 | fenofibric acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | BGF9MN2HU1 | FENOFIBRIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 24852 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27077290 | fenofibric acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83804 | Fenofibric Acid | One source FDA |
| DrugBank | DB13873 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.